Treatment of inflammatory bowel disease by chemokine receptor-targeted leukapheresis.
Eberhardson M, Marits P, Jones M, Jones P, Karlen P, Karlsson M, Cotton G, Woznica K, Maltman B, Glise H, Winqvist O.
Eberhardson M, et al.
Clin Immunol. 2013 Oct;149(1):73-82. doi: 10.1016/j.clim.2013.05.021. Epub 2013 Jun 13.
Clin Immunol. 2013.
PMID: 23892544
Clinical Trial.